Tiazofurin and its analogues were under investigation for potential use in the treatment of cancer, though side effects such as pleuropericarditis and a flu-like syndrome precluded further development.
Research into Tiazofurin and its related compounds was halted due to concerns over their potential to treat cancer, as they caused unpleasant side effects like pleuropericarditis and a flu-like illness.